These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1282922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM, Colonna P.
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract] [Full Text] [Related]

  • 3. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Santoro A, Viviani S, Villarreal CJ, Bonfante V, Delfino A, Valagussa P, Bonadonna G.
    Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
    [Abstract] [Full Text] [Related]

  • 4. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M.
    Clin Ter; 2001 Mar; 152(3):203-6. PubMed ID: 11692542
    [No Abstract] [Full Text] [Related]

  • 5. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 6. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R.
    Cancer Treat Rep; 1984 Mar; 68(7-8):947-51. PubMed ID: 6204754
    [Abstract] [Full Text] [Related]

  • 7. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.
    Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hodgkin's disease: controversies and challenges for the future.
    Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL.
    Haematologica; 1991 Apr; 76(4):263-79. PubMed ID: 1724436
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H.
    Cancer Treat Res; 1989 Apr; 41():241-6. PubMed ID: 2484293
    [No Abstract] [Full Text] [Related]

  • 16. [Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
    Hermann R, Greminger P, Dommann-Scherrer C, Krestin GP, Stahel R.
    Schweiz Med Wochenschr; 1994 Sep 24; 124(38):1666-71. PubMed ID: 7524146
    [Abstract] [Full Text] [Related]

  • 17. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7555-64. PubMed ID: 16234521
    [Abstract] [Full Text] [Related]

  • 18. Third-line salvage chemotherapy in Hodgkin's disease.
    Bonadonna G, Viviani S, Valagussa P, Bonfante V, Santoro A.
    Semin Oncol; 1985 Mar 20; 12(1 Suppl 2):23-5. PubMed ID: 2579440
    [Abstract] [Full Text] [Related]

  • 19. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
    Diehl V.
    J Clin Oncol; 2003 Feb 15; 21(4):583-5. PubMed ID: 12586791
    [No Abstract] [Full Text] [Related]

  • 20. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G, Viviani S, Bonfante V, Gianni AM, Valagussa P.
    Eur J Cancer; 2005 May 15; 41(7):998-1006. PubMed ID: 15862748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.